GL1X · GenesisL1 explorer

MolNFT v1 · #87913 · protein

Interrogating HIV integrase for compounds that bind- a sampl challenge

4CF8: “Interrogating HIV integrase for compounds that bind- a sampl challenge”. X-ray diffraction, 3 ligands (V7H, SO4, CL), 6 pockets (best druggability 0.66). MolNFT v1 #87913 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4CF8
Type
protein
Length
298 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.7
UniProt
Q76353
Ligands
V7H, SO4, CL
Pockets
6 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BIntegrase (EC 2.7.7.7)protein14953% helix, 21% strandQ76353

Ligands and binding sites

  • V7H · (2S)-2-(3-hydroxy-3-oxopropyl)-6-[[[2-[(phenylmethyl)carbamoyl]phenyl]methylamino]methyl]-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B
  • ACY · Acetic acid · additive · 5 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13720.660.8042ACY, V7H
2950.480.8124ACY
3990.480.8124ACY
41140.470.7818V7H
51490.440.7634empty

Interfaces

1 interface between chains.

  • A–B · 1438 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 4CF8 · Interrogating HIV integrase for compounds that bind- a SAMPL challenge · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.